Fundraising Fox

Frequency Therapeutics

Woburn, US · Founded 2014 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

Frequency Therapeutics was founded in 2014 by David Lucchino and Christopher R. Loose.

DL
David LucchinoCo-founder
CR
Christopher R. LooseCo-founder

Board

RLRobert Langer
Robert LangerBoard directorScientific Advisory Committee Member at Polaris Partners
MK
Marc KozinBoard director
MC
Marc CohenBoard director
TB
Timothy BarberichBoard director

Investors · 3

venBio PartnersSan Francisco
AlexandriareportedPasadenavia Joel S. Marcus · board
Kendall Capital PartnersreportedBostonvia Robert Langer · board

Reported raises · per SEC filings

Form D private placements

$136.3M disclosed across 3 rounds · 2017–2020

▶$42.3MraisedJul 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy J. BarberichDirector
  • Marc A. CohenDirector
  • Robert S. LangerDirector
  • Dana HiltExecutive Officer
  • David L. LucchinoExecutive Officer, Director
  • Joel S. MarcusDirector
  • Christopher R. LooseExecutive Officer
  • Wendy S. ArnoldExecutive Officer
  • Richard MitranoExecutive Officer
  • Michael HuangDirector
  • Carl P. LeBelExecutive Officer
Offering amount
$42.3M
Amount sold
$42.3M
Sales commissions
$2M
Placement agents
Cowen and Company, LLC
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$62MraisedJul 2019 · 80 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert S. LangerDirector
  • Michael HuangDirector
  • Richard MitranoExecutive Officer
  • Carl LebelExecutive Officer
  • David LucchinoExecutive Officer, Director
  • Christopher R. LooseExecutive Officer
  • Timothy BarberichDirector
  • Joel MarcusDirector
  • Marc CohenDirector
Offering amount
$62M
Amount sold
$62M
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32MraisedApr 2017 · 90 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LucchinoExecutive Officer, Director
  • Christopher R. LooseExecutive Officer
  • Marc KozinDirector
  • Robert LangerDirector
  • Marc CohenDirector
  • Timothy BarberichDirector
Offering amount
$32M
Amount sold
$32M
First sale
Mar 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Frequency Therapeutics went on to found or lead other companies.

Marc CohenChairmanFounded Regenacy Pharmaceuticals +2Jeffrey KarpCo-Founder, Member of the Regenerative Medicine Advisory BoardFounded Tissium +2Robert LangerDirectorFounded Lyndra +1

In the news

Frequency Therapeutics inks $625m deal with Astellas, adds $62m Series C - MassDevicemassdevice.com · Jul 2019Frequency Therapeutics raises another $62 million | STATstatnews.com · Jul 2019Frequency Therapeutics raises $42m for hearing regeneration drug - Drug Delivery Businessdrugdeliverybusiness.com · Jan 2019Buy Frequency Therapeutics Stock – FREQ Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

Who founded Frequency Therapeutics?
Frequency Therapeutics was founded by David Lucchino, Christopher R. Loose in 2014.
Who are Frequency Therapeutics's investors?
Frequency Therapeutics's investors include venBio Partners, Alexandria, Kendall Capital Partners.
How much funding has Frequency Therapeutics raised?
Frequency Therapeutics has disclosed $136.3M raised across 3 rounds.
Where is Frequency Therapeutics headquartered?
Frequency Therapeutics is headquartered in Woburn, US.